跳至主要内容
临床试验/TCTR20210216003
TCTR20210216003已完成4 期

Efficacy of Vonoprazan based dual therapy with amoxicillin versus standard triple therapy for Helicobacter pylori eradication in Thailand

Gastroenterological association of Thailand0 个研究点目标入组 128 人开始时间: 2021年2月16日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
128

研究概览

简要总结

7-days VA-dual regimen is non-inferiority than 14-days OAC-triple regimen as a first-line H. pylori eradication therapy and incidence of adverse events was a trend to lower in VA-dual subjects.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(—)
性别
All

入选标准

  • 1) subjects undergoing gastrointestinal endoscopy at Department of Gastroenterology Phramongkutklao Hospital during 1 August 2019 to 28 February 2020
  • 2) aged 18 years or over
  • 3) diagnosis of H.pylori infection using upper GI endoscopy with the rapid urease test and positive test result of the infection.

排除标准

  • 1) GFR <30 ml/min/1.73m2
  • 2) history of drug resistance used in research studies
  • 3) pregnant women or breastfeeding mothers
  • 4) History treatment of H.pylori infection
  • 5) Subjects in critical condition
  • 6) Subjects to be diagnosed with neuroendocrine tumor, HIV infection

研究者

相似试验